Furonazide

Furonazide
Names
Preferred IUPAC name
N′-[1-(Furan-2-yl)ethylidene]pyridine-4-carbohydrazide
Other names
4-Pyridinecarboxylic acid [1-(2-furanyl)ethylidene]hydrazide
Furilazone
Clitizina
Menazone
FKI
Identifiers
3D model (JSmol)
ChEBI
ChemSpider
ECHA InfoCard 100.020.375 Edit this at Wikidata
EC Number
  • 222-411-6
UNII
  • InChI=1S/C12H11N3O2/c1-9(11-3-2-8-17-11)14-15-12(16)10-4-6-13-7-5-10/h2-8H,1H3,(H,15,16)/b14-9-
    Key: GNDPAVKYAUIVEB-ZROIWOOFSA-N
  • C/C(=N/NC(=O)c1ccncc1)/c2ccco2
Properties
C12H11N3O2
Molar mass 229.239 g·mol−1
Appearance crystals
Melting point 199 to 201.5 °C (390.2 to 394.7 °F; 472.1 to 474.6 K)
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

Furonazide is a crystalline tuberculostatic drug substance with a reported melting point of 199-201.5 °C.[1]

Synthesis

Furonazide was first prepared in 1955 by Miyatake from isoniazid and 2-Acetylfuran by refluxing in ethanol, followed by filtration of the crystalline product.[1][2]

Applications

Furonazide has shown bacteriostatic action and is tuberculostatic at levels of 10−8 molar.[1] The in vitro antibacterial activity of furonazide against Bacillus Calmette-Guerin was found to be essentially equal to that of isoniazid on an equimolar basis.[3] In vivo studies in the guinea pig showed furonazide slightly more active than isoniazid as a tuberculostatic agent.[4] The drug has relatively low toxicity. The median lethal dose (LD50, rat oral) was reported as 2,600 mg/kg.[5]

References

  1. ^ a b c Kazuo Miyatake, “Derivatives of isonicotinic acid hydrazide”, Japanese Patent 32,002,484 B4 (1957)
  2. ^ Kazuo Miyatake; Ichimura, Shozo; Nagasaki, Senkichi; Hoji, Kazuhiko (1955). "Syntheses of compounds related to isonicotinic acid hydrazide. III. Antitubercular compounds". Yakugaku Zasshi. 75: 1066–9. doi:10.1248/yakushi1947.75.9_1066.
  3. ^ Kiichiro Kakemi; Sezaki, Hitoshi; Iwamoto, Kikuo; Sano, Yukito (1969). "Stability of drugs in biological media. II. Relations between the stability in culture media and antibacterial activity of some isoniazid derivatives". Chemical & Pharmaceutical Bulletin. 17 (8): 1623–8. doi:10.1248/cpb.17.1623. PMID 4981613.
  4. ^ Giovanni Pacilio; Pagnini, Pietro; Genazzani, Enrico (1964). "Tuberculostatic activity of some isoniazid derivatives administered to guinea pigs at different time intervals". Atti della Societa Italiana delle Scienze Veterinarie. 18: 631–6.
  5. ^ "Drugs - Synonyms and Properties" data were obtained from Ashgate Publishing Co. (US)

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.